Greentown Labs CEO to resign after less than a year on the job
Biotech launches with $65M to focus on MS drugs
Can AI help consumers buy marijuana? Mass. cannabis firm to find out.
Boston biotech launched by J&J, Third Rock files plans for IPO
GBH general manager to leave station after four years
Peabody & Arnold attorney named president of MBLA
Taking F1 Arcade for a spin
CyberArk buys 400-employee Utah company for $1.5B
Are investors re-entering the housing market after two-year retreat?
It's not just housing: Another soaring cost is squeezing employees
Five things you need to know, and it’s the Orange Line’s turn
On the Waterfront | A Union Wharf Penthouse
Authors and Innovators: Nakedly unafraid and heading outside
Here's how much startup founders make in 2024
Who left after tech titans returned to office? A surprising group.
Avangrid's board agrees to be taken private by Spanish energy giant
David Beckham joins SharkNinja as 'global brand ambassador'
Some employers are weighing a six-day workweek
After hat trick, Devens developer to build a 4th manufacturing site
Three-house beachfront compound in Provincetown for under $10M
Cerence CFO resigns after two months on the job
Feast & Fettle expands into New York, New Jersey
Salem investment startup Mainvest is shutting down
Fort Point lab wins BPDA approval despite chair’s climate misgivings
Mike Fanning wants Advisor360 on every wealth advisor’s desktop
Five things to know, and how I know last year was bad for businesses
Steward crisis could raise employer insurance costs
Biotech CEO: Bayh-Dole 'fix' won't lower drug prices
- 1 of 371
- Next